LAB INNOVATIONS 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

LAB INNOVATIONS 2012


LAB INNOVATIONS 2012 is the UK’s only dedicated showcase for laboratory technology and consumable, analytical and biotech equipment.

Set to deliver great content for lab professionals looking for the latest innovations, career development, new skills and technology, this is your opportunity to access some of the UK's best speakers and industry conference content for free.

By attending the event, you’ll gain access to a complimentary conference featuring world renowned speakers delivering content programmed by the Royal Society of Chemistry. In addition, Campden BRI will lead focused career development and technique analysis seminars providing inspiration for your business and personal progression.

Register today for FREE your priority access barcode.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges

Click here